FULGENT GENETICS, INC. Public Float
FULGENT GENETICS, INC. (FLGT) had Public Float of $284.30 million as of 2025-06-30, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-27
- 2025-06-30: Entity Public Float $284.30M.
- 2024-06-30: Entity Public Float $325.60M.
- 2023-06-30: Entity Public Float $628.50M.
- 2022-06-30: Entity Public Float $977.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $284.30M 10-K · filed 2026-02-27 |
| 2024-06-30 | $325.60M 10-K · filed 2025-02-28 |
| 2023-06-30 | $628.50M 10-K · filed 2024-02-28 |
| 2022-06-30 | $977.90M 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.60B 10-K · filed 2022-02-28 |
| 2020-06-30 | $191.30M 10-K · filed 2021-03-08 |
| 2019-06-30 | $38.80M 10-K · filed 2020-03-13 |
| 2018-06-30 | $22.40M 10-K · filed 2019-03-22 |
| 2017-06-30 | $33.70M 10-K · filed 2018-03-20 |
| 2016-06-30 | $0.00 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |